We are pushing the boundaries of science with human-induced pluripotent stem cells (hiPSCs) and innovative gene-editing technologies. While our vision is to contribute to a future free from single-gene mutation diseases, we have a clear, immediate promise to fulfill. Our journey begins with our first and most important goal: finding a cure for LGMD 2B/R2.